Therapy and Outcomes of Patients with Relapsed Nonmetastatic Rhabdomyosarcoma: A Report from the French Society of Pediatric Oncology Malignant Mesenchymal Tumor Committee.

Fiche publication

Date publication

décembre 2024

Journal

Cancer medicine

Auteurs

Membres identifiés du Cancéropôle Est :
Dr BERNIER-CHASTAGNER Valérie , Dr JANNIER Sarah

Tous les auteurs :
Sevrin F, Bogart E, Orbach D, Le Deley MC, Berlanga P, Bernier V, Corradini N, Fayard C, Guerin F, Jannier S, Karanian M, Proust S, Rome A, Verité C, Minard-Colin V, Defachelles AS

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/39610307

Résumé

The prognosis for patients with relapse of localized rhabdomyosarcoma (RMS) remains poor, with limited evidence for optimal second-line therapy. This study describes the management and outcomes of relapsed RMS patients in France.